IV-delivered therapy for canine OA advances toward FDA approvalMay 7, 2026A study of intravenous uterine-derived mesenchymal stromal cells (UMSCs) in dogs with “naturally occurring OA” reportedly shows improvements in pain and mobility, with no serious treatment-related adverse events.
SPONSORED CONTENTFast Itch Relief for Canine PatientsA treatment for allergic and atopic dermatitis, given just once a day. Visibly improves itch fast. + Learn More Now
What they don't teach you about canine osteoarthritis in veterinary schoolMay 6, 2026In vet school, canine osteoarthritis (OA) is often presented within the musculoskeletal disease section as a cartilage disease. The problem with this focus is that cartilage does not have nerve endings, which begs the question: why is OA so painful?
A close look at monoclonal antibodies for managing canine OA painJanuary 15, 2026As veterinary care continues to shift toward preventive medicine and lifelong wellness, there is growing momentum around improving earlier detection and more consistent pain management. Among the emerging therapeutic options is a new class of biologics: monoclonal antibodies (mAbs).
Managing OA in dogs and catsDecember 23, 2025Various degrees of evidence exist for the use of various modalities in OA therapy in our canine and feline patients. Selecting therapies based on sound evidence-based veterinary medicine is paramount, as it gives the greatest likelihood of success. Ultimately, veterinarians need to combine experience and medical evidence to provide a multi-modal approach to the disease.
Rethinking Our Approach to Canine OA: Treating synovial inflammationOctober 1, 2025It’s time to reframe arthritis not just as a painful condition, but as a disease of rampant synovial inflammation. In adopting a proactive treatment strategy that is aimed at modulating the inflammatory process, veterinarians can now provide more effective, long-term care.
A New Way Forward in Canine Osteoarthritis: Targeting Pain and Inflammation at Its SourceJuly 1, 2025The traditional approach to canine osteoarthritis (OA) has largely focused on treatments such as NSAIDs, joint supplements, stem cell, PRP, and anti-nerve growth factor (anti-NGF) injections. This raises a critical question: What if we could do more than manage symptoms? What if we could target the inflammation driving the disease?
A closer look at OA supplements—Part 2May 17, 2025In this installment, we will discuss green-lipped mussel, turmeric, undenatured collagen II, CBD products, and a recent literature review of each active nutraceutical.
A closer look at OA supplements—Part 1March 15, 2025Osteoarthritis (OA) is common in dogs and cats. Often, the practitioner utilizes multimodal approaches to treatment, offering anti-inflammatory medications and dietary supplements. Let's look at some options for your OA patient.
FIP, radiation, and other advances key to practicesAugust 5, 2024It is not always easy keeping up with what is happening and new in veterinary medicine. Four experts share more about recent advances in the field that could affect your practice.
Managing OA requires controlling inflammationMarch 3, 2024While sometimes called an “old dog disease,” canine osteoarthritis (OA) can affect dogs of any age, with risk factors that include breed, intense activity, obesity, join injury, and joint surgery.
